Knight Therapeutics Inc (TSX:GUD) Share Price

Company Profile

Business description
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Latin America and select international markets . The company finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights. Geographically the company generates revenue from Brazil, Colombia, Argentina, Rest of LATAM, Canada, and Other, with the majority revenue generated from the Brazil region.
Contact
3400 De Maisonneuve West
Suite 1055
MontrealQCH3Z 3B8
CAN
T: +1 514 484-4483
E: [email protected]
https://www.gud-knight.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
745

Recommended

Simplification plan complete, organic growth now the focus.

Nathan Zaia | 20 August 2025

Cost containment and growing revenue bode well for profit margins.

Adrian Atkins | 20 August 2025

Sales growth at CSL was lower than expected but streamlining the business has its perks.

Shane Ponraj, CFA | 19 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,284.20	51.60	0.56%
CAC 40	7,956.00	17.03	-0.21%
DAX 40	24,264.41	12.56	-0.05%
Dow JONES (US)	44,938.31	16.04	0.04%
FTSE 100	9,297.23	9.09	0.10%
HKSE	25,067.22	98.72	-0.39%
NASDAQ	21,172.86	142.09	-0.67%
Nikkei 225	42,610.17	278.38	-0.65%
NZX 50 Index	13,194.07	122.77	0.94%
S&P 500	6,395.78	15.59	-0.24%
S&P/ASX 200	9,019.10	45.40	0.51%
SSE Composite Index	3,771.10	4.89	0.13%